| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.037 | 0.5 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.5 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |